App Pharmaceuticals (ABBI) Inactive 10-Q2003 Q2 Quarterly report

Filed: 13 Aug 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: absorb, abstained, accumulated, accumulating, accumulation, affiliation, animal, APP, appointment, biological, biologically, block, broker, Bulletin, Canada, cell, cervical, Chemistry, clarifying, coincident, combination, commenced, commensurate, committed, construction, declared, dedicated, delivery, director, discovery, disinterested, distinct, dividend, dosing, Dr, embedded, Ernst, excluding, explore, extensive, facilitate, failed, Fast, FIN, firm, focused, goal, guidance, hedging, hired, human, II, incumbent, instrument, issuer, law, LLP, low, measuring, melanoma, modified, multiple, nanoparticle, nationally, occur, paclitaxel, pivotal, platform, preclinical, president, proposal, proxy, ratification, ratified, recover, recusing, regimen, residual, restatement, retroactive, scope, shareholder, single, strength, submission, taxane, therapeutic, therapy, track, trial, unanimously, unblinded, understand, unrelated, upward, valuation, vote, voted, voting, weekly, Young

Removed: adversely, goodwill, indefinite, insurance, intangible, longer, scheduled

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ABBI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION

In connection with the periodic report of American Pharmaceutical Partners, Inc. (the “Company”) on Form 10-Q for the quarter ending June 30, 2003 as filed with the Securities and Exchange Commission (the “Report”), I, Nicole S. Williams, Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

	(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

	(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: August 13, 2003	/s/ NICOLE S. WILLIAMS

	Nicole S. Williams Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.